← Open Payments lookup

ADEKUNBI IMALENOWA: Open Payments

NPI 1073144937 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,632 in 80 payments from 12 companies in 2025. Trend: 2023 $770 · 2024 $1,023 · 2025 $1,632

Food & beverage: $1,520Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$402
Teva Pharmaceuticals USA, Inc.18$371
Janssen Pharmaceuticals, Inc17$284
Vanda Pharmaceuticals Inc.9$175
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$113
Alkermes, Inc.4$79
Lundbeck LLC4$64
E.R. Squibb & Sons, L.L.C.2$39
Otsuka America Pharmaceutical, Inc.2$38
Axsome Therapeutics, Inc.2$29

Products named: INGREZZA, INVEGA SUSTENNA, FANAPT, UZEDY, AUSTEDO XR, CAPLYTA, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.